株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヒアルロン酸の世界市場 - 市場規模、シェア、動向分析

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis (Single Injection, Three Injection, Five Injection), Ophthalmic, Vesicoureteral Reflux), By Region, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 370474
出版日 ページ情報 英文 150 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
ヒアルロン酸の世界市場 - 市場規模、シェア、動向分析 Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis (Single Injection, Three Injection, Five Injection), Ophthalmic, Vesicoureteral Reflux), By Region, And Segment Forecasts, 2020 - 2027
出版日: 2020年02月13日 ページ情報: 英文 150 Pages
概要

当レポートでは、世界のヒアルロン酸市場を調査し、市場の概要、用途・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 市場区分と範囲
  • 調査方法
  • 情報調達
  • データ分析
  • 市場の定式化と検証
  • モデル詳細
  • 二次出典リスト
  • 一次出典リスト
  • 略語リスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • 市場の見通し:セグメント別
  • 市場の見通し

第3章 市場変数、動向、範囲

  • 市場の見通し
  • 市場セグメンテーション
  • 普及と成長見通しのマッピング
  • 市場分析ツール

第4章 ヒアルロン酸市場の予測と動向分析:用途別

  • 市場動向の分析:用途別
  • 皮膚充填剤
  • 変形性関節症
    • 単回投与
    • 3回投与
    • 5回投与
  • 眼科
  • 膀胱尿管逆流

第5章 ヒアルロン酸市場の予測と動向分析:地域別

  • 市場シェア:地域別(実績値・予測値)
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • インド
    • 中国
    • 日本
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ地域
    • 南アフリカ

第6章 償還シナリオ

  • 償還シナリオ:製品別
  • 償還シナリオ:地域別

第7章 競合情勢

  • 近年の開発動向と影響分析:参入企業別
  • 戦略の枠組み
  • ベンダー情勢
  • 企業ポジショニング分析
  • 企業プロファイル
    • Allergan
    • Sanofi
    • Genzyme Corporation
    • Anika Therapeutics, Inc.
    • Salix Pharmaceuticals, Inc.
    • 生化学工業
    • Galderma S.A
    • Zimmer Biomet
    • Smith & Nephew Plc
    • Ferring B.V.
    • Lifecore Biomedical, LLC
    • HTL Biotechnology
    • 資生堂
    • Bloomage Freda Biopharm Co. Ltd.
    • LG Life Sciences Ltd
    • マルハニチロ
    • Fluidigm Corporation

第8章 提言

図表

List of Tables

  • TABLE 1 North America hyaluronic acid market, by country, 2016 - 2027 (USD Million)
  • TABLE 2 North America hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 3 U.S. hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 4 Canada hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 5 Europe hyaluronic acid market, by country, 2016 - 2027 (USD Million)
  • TABLE 6 Europe hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 7 U.K. hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 8 Germany hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 9 France hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 10 Italy hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 11 Spain hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 12 Asia Pacific hyaluronic acid market, by country, 2016 - 2027 (USD Million)
  • TABLE 13 Asia Pacific hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 14 Japan hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 15 China hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 16 India hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 17 Latin America hyaluronic acid market, by country, 2016 - 2027 (USD Million)
  • TABLE 18 Latin America hyaluronic acid market by application, 2016 - 2027 (USD MILLION)
  • TABLE 19 Brazil hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 20 Mexico hyaluronic acid market by application, 2016 - 2027 (USD Million)
  • TABLE 21 MEA hyaluronic acid market, by country, 2016 - 2027 (USD Million)
  • TABLE 22 MEA hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 23 South Africa hyaluronic acid market, by application, 2016 - 2027 (USD Million)
  • TABLE 24 List of secondary sources
  • TABLE 25 List of abbreviation

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hyaluronic acid market summary, 2019 (USD Million)
  • Fig. 9 Hyaluronic acid market segmentation
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Ratio of adult population to total population (billion)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 PESTEL analysis
  • Fig. 17 Hyaluronic acid market: Application movement analysis
  • Fig. 18 Hyaluronic acid application outlook: Key takeaways
  • Fig. 19 Dermal fillers market, 2016 - 2027 (USD Million)
  • Fig. 20 Osteoarthritis market, 2016 - 2027 (USD Million)
  • Fig. 21 Single injection market, 2016 - 2027 (USD Million)
  • Fig. 22 Three injection market, 2016 - 2027 (USD Million)
  • Fig. 23 Five injection market, 2016 - 2027 (USD Million)
  • Fig. 24 Ophthalmic market, 2016 - 2027 (USD Million)
  • Fig. 25 Vesicoureteral reflux market, 2016 - 2027 (USD Million)
  • Fig. 26 Regional outlook, 2019 & 2027
  • Fig. 27 Regional market place: Key takeaways
  • Fig. 28 Regional market place: Key takeaways
  • Fig. 29 North America hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 30 U.S. hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 31 Canada hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 32 Europe hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 33 Germany hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 34 U.K. hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 35 France hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 36 Italy hyaluronic acid market, 2016 - 2027 (USD million)
  • Fig. 37 Spain hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 38 Asia Pacific hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 39 Japan hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 40 China hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 41 India hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 42 Latin America hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 43 Brazil hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 44 Mexico hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 45 MEA hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 46 South Africa hyaluronic acid market, 2016 - 2027 (USD Million)
  • Fig. 47 Strategy framework
  • Fig. 48 Market position analysis
目次
Product Code: 978-1-68038-333-1

The global hyaluronic acid market size is expected to reach USD 16.6 billion by 2027, expanding at a CAGR of 8.1%, according to a new report by Grand View Research, Inc. Factors such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers of this market.

The market is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with growing awareness about anti-aging products is fueling the growth. The efficacy and evident results of hyaluronic acid based dermal fillers are attracting this population base.

The global increase in population also results in an increased demand for antiaging cosmetic and aesthetic treatments. Owing to its distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels, hyaluronic acid products are directly affected by growing demand for minimally invasive antiaging solutions. The minimal adverse effects, lower pain, shorter recovery time, and lesser postsurgical complications make minimally invasive surgeries significantly attractive.

Further key findings from the study suggest:

  • The osteoarthritis segment held the largest share in 2019. In 2013, more than 27 million people were suffering from osteoarthritis. Viscosupplements are gaining popularity as a cure in pain management. Use of hyaluronan as a treatment for osteoarthritis has been approved by the U.S. FDA in 1997 and has gained substantial market share
  • The rising obesity resulting in osteoarthritis and joint pain has increased the demand for hyaluronic acid injections as treatment. With the prevailing consumer trend, which favors convenience over higher costs, companies such as Genzyme (Sanofi-Aventis) and Zimmer have launched single-injection products. The 2014 FDA approval for single-injection treatment "MONOVISC" is expected to further fuel the growth of the single-injection product segment
  • Cosmetic surgeries are booming with approximately 14 million minimally invasive procedures performed every year. In 2013, hyaluronan-based facial fillers received FDA approval, which is used in corrective measures, anti-aging procedure, and filling fine lines. These dermal fillers constitute a large share in these procedures and witnessed 8% growth in the year 2014
  • Growing preference for short-treatment regimens, even though high priced, and growing prevalence of target diseases, such as osteoarthritis, are high impact rendering factors that can be attributed for the large share of this region. In 2019, the most lucrative applications of hyaluronic acid in the North American region were in the form of dermal fillers and viscosupplements for management of osteoarthritis
  • Hyaluronic acid market in Asia Pacific region is anticipated to emerge as the fastest growing region during the forecast period. The growing geriatric population in China and Japan provides a large customer base for anti-aging products and services. Increasing awareness about applications of hyaluronan and its efficacy fuels the demand. In addition, stabilizing economies leaves the middle-class population with surplus money to spend on these procedures

The industry is presently dominated by key participants such as F. Hoffmann-La Roche Ltd.; Seikagaku Corporation; Galderma S.A; Sanofi (Genzyme); Anika Therapeutics Inc.; Salix Pharmaceuticals; Zimmer Holdings Inc.; Allergan Inc.; Ferring Pharmaceuticals, Inc.; and Smith & Nephew Plc.

Table of Contents

Chapter 1 Research Objective

  • 1.1 Objective - 1
  • 1.2 Objective - 2
  • 1.3 Objective - 3
  • 1.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Application
    • 2.2.2 Region
  • 2.3 Competitive Insights
  • 2.4 Hyaluronic Acid Market Snapshot

Chapter 3 Hyaluronic Acid Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Market Segmentation
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
    • 3.3.2 Market influencer analysis
  • 3.4 Penetration and Growth Prospect Mapping
  • 3.5 Market Dynamics
    • 3.5.1 Market driver analysis
      • 3.5.1.1 Increasing geriatric population and prevalence of osteoarthritis
      • 3.5.1.2 Growing demand for antiaging solutions and minimally invasive aesthetic treatments
      • 3.5.1.3 Growing application in regenerative medicine and tissue engineering
      • 3.5.1.4 Market approval and launch of new products
    • 3.5.2 Market restraint analysis
      • 3.5.2.1 High cost and side effects associated with hyaluronic acid cycles
  • 3.6 Business Environment Analysis Tools
    • 3.6.1 Industry analysis - Porter's
      • 3.6.1.1 Competitive rivalry
      • 3.6.1.2 Threat of new entrants
      • 3.6.1.3 Bargaining power of buyers
      • 3.6.1.4 Bargaining power of suppliers
      • 3.6.1.5 Threat of substitutes
    • 3.6.2 PESTEL analysis
      • 3.6.2.1 Political landscape
      • 3.6.2.2 Economic and social landscape
      • 3.6.2.3 Technology landscape
  • 3.7 Major Deals & Strategic Alliances Analysis
    • 3.7.1 Joint ventures
    • 3.7.2 Mergers & acquisitions

Chapter 4 Hyaluronic Acid Market: Application Estimates & Trend Analysis

  • 4.1 Segment Dashboard
  • 4.2 Hyaluronic Acid Market: Application Movement Analysis, USD Million, 2019 & 2027
    • 4.2.1 Dermal fillers
      • 4.2.1.1 Dermal fillers market, 2016 - 2027 (USD Million)
    • 4.2.2 Osteoarthritis
      • 4.2.2.1 Osteoarthritis market, 2016 - 2027 (USD Million)
      • 4.2.2.1.1 Single injection
      • 4.2.2.1.1.1 Single injection market, 2016 - 2027 (USD Million)
      • 4.2.2.1.2 Three injection
      • 4.2.2.1.2.1 Three injection market, 2016 - 2027 (USD Million)
      • 4.2.2.1.3 Five injection
      • 4.2.2.1.3.1 Five injection market, 2016 - 2027 (USD Million)
    • 4.2.3 Ophthalmic
      • 4.2.3.1 Ophthalmic market, 2016 - 2027 (USD Million)
    • 4.2.4 Vesicoureteral reflux
      • 4.2.4.1 Vesicoureteral market, 2016 - 2027 (USD Million)

Chapter 5 Hyaluronic Acid Market: Regional Estimates & Trend Analysis, By Application

  • 5.1 Regional Market Share Analysis, 2019 & 2027
  • 5.2 Regional Market Dashboard
  • 5.3 Regional Market Snapshot (Countries)
  • 5.4 North America
    • 5.4.1 North America hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.4.2 U.S.
      • 5.4.2.1 U.S. hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.4.3 Canada
      • 5.4.3.1 Canada hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
  • 5.5 Europe
    • 5.5.1 Europe hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.5.2 Germany
      • 5.5.2.1 Germany hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.5.3 U.K.
      • 5.5.3.1 U.K. hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.5.4 France
      • 5.5.4.1 France hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.5.5 Italy
      • 5.5.5.1 Italy hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.5.6 Spain
      • 5.5.6.1 Spain hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.6.2 Japan
      • 5.6.2.1 Japan hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.6.3 China
      • 5.6.3.1 China hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.6.4 India
      • 5.6.4.1 India hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
  • 5.7 Latin America
    • 5.7.1 Latin America hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.7.2 Brazil
      • 5.7.2.1 Brazil hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.7.3 Mexico
      • 5.7.3.1 Mexico hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)
    • 5.8.2 South Africa
      • 5.8.2.1 South Africa hyaluronic acid market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 6 Reimbursement Outlook

  • 6.1 Reimbursement By Product
    • 6.1.1 Gel-one
    • 6.1.2 EUFLEXXA
    • 6.1.3 Synvisc-One
    • 6.1.4 Supartz
    • 6.1.5 Hyalgan
    • 6.1.6 Monovisc
    • 6.1.7 Orthovisc
    • 6.1.8 Others
  • 6.2 Reimbursement By Region
    • 6.2.1 Canada
    • 6.2.2 China
    • 6.2.3 Japan
    • 6.2.4 India
    • 6.2.5 Brazil
    • 6.2.6 South Africa
    • 6.2.7 Europe
      • 6.2.7.1 U.K.
      • 6.2.7.2 Germany
      • 6.2.7.3 France
      • 6.2.7.4 Italy
      • 6.2.7.5 Spain

Chapter 7 Competitive Landscape

  • 7.1 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
  • 7.2 Vendor Landscape
    • 7.2.1 List of key distributors and channel partners
    • 7.2.2 Strategy mapping
      • 7.2.2.1 Partnerships
      • 7.2.2.2 Launch of new products
      • 7.2.2.3 Merger & acquisition
      • 7.2.2.4 Geographical expansion
      • 7.2.2.5 Marketing & promotions
    • 7.2.3 Company market position analysis (market presence, geographic presence, product portfolio, startegic initiatves)
  • 7.3 Company Profiles
    • 7.3.1 Allergan
      • 7.3.1.1 Company overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product benchmarking
      • 7.3.1.4 Strategic initiatives
      • 7.3.1.5 SWOT analysis
      • 7.3.1.6 Strategic initiatives
    • 7.3.2 Sanofi
      • 7.3.2.1 Company overview
      • 7.3.2.2 Financial performance
      • 7.3.2.3 Product benchmarking
      • 7.3.2.4 Strategic initiatives
      • 7.3.3.5 SWOT analysis
      • 7.3.4.6 Strategic initiatives
    • 7.3.3 Genzyme Corporation
      • 7.3.3.1 Company overview
      • 7.3.3.2 Financial performance
      • 7.3.3.3 Product benchmarking
      • 7.3.3.4 Strategic initiatives
      • 7.3.3.5 SWOT analysis
      • 7.3.3.6 Strategic initiatives
    • 7.3.4 Salix Pharmaceuticals, Inc.
      • 7.3.4.1 Company overview
      • 7.3.4.2 Financial performance
      • 7.3.4.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives
      • 7.3.4.5 SWOT analysis
      • 7.3.4.6 Strategic initiatives
    • 7.3.5 Seikagaku Corporation
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.5.4 Strategic initiatives
      • 7.3.5.5 SWOT analysis
      • 7.3.5.6 Strategic initiatives
    • 7.3.6 F. Hoffmann-La Roche AG
      • 7.3.6.1 Company overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product benchmarking
      • 7.3.6.4 Strategic initiatives
      • 7.3.6.5 SWOT analysis
      • 7.3.6.6 Strategic initiatives
    • 7.3.7 Galderma S.A.
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
      • 7.3.7.4 Strategic initiatives
      • 7.3.7.5 SWOT analysis
      • 7.3.7.6 Strategic initiatives
    • 7.3.8 Zimmer Biomet
      • 7.3.8.1 Company overview
      • 7.3.8.2 Financial performance
      • 7.3.8.3 Product benchmarking
      • 7.3.8.4 Strategic initiatives
      • 7.3.8.5 SWOT analysis
      • 7.3.8.6 Strategic initiatives
    • 7.3.9 Smith & Nephew Plc
      • 7.3.9.1 Company overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.9.4 Strategic initiatives
      • 7.3.9.5 SWOT analysis
      • 7.3.9.6 Strategic initiatives
    • 7.3.10 Ferring B.V.
      • 7.3.10.1 Company overview
      • 7.3.10.2 Financial performance
      • 7.3.10.3 Product benchmarking
      • 7.3.10.4 Strategic initiatives
      • 7.3.10.5 SWOT analysis
      • 7.3.10.6 Strategic initiatives
    • 7.3.11 Lifecore Biomedical, LLC
      • 7.3.11.1 Company overview
      • 7.3.11.2 Financial performance
      • 7.4.11.3 Product benchmarking
      • 7.4.11.4 Strategic initiatives
      • 7.4.11.5 SWOT analysis
      • 7.4.11.6 Strategic initiatives
    • 7.3.12 HTL Biotechnology
      • 7.3.12.1 Company overview
      • 7.3.12.2 Financial performance
      • 7.4.12.3 Product benchmarking
      • 7.4.12.4 Strategic initiatives
      • 7.4.12.5 SWOT analysis
      • 7.4.12.6 Strategic initiatives
    • 7.3.13 Shiseido Company, Limited
      • 7.3.13.1 Company overview
      • 7.3.13.2 Financial performance
      • 7.4.13.3 Product benchmarking
      • 7.4.13.4 Strategic initiatives
      • 7.4.13.5 SWOT analysis
      • 7.4.13.6 Strategic initiatives
    • 7.3.14 Bloomage Freda Biopharm Co. Ltd.
      • 7.3.14.1 Company overview
      • 7.3.14.2 Financial performance
      • 7.4.14.3 Product benchmarking
      • 7.4.14.4 Strategic initiatives
      • 7.4.14.5 SWOT analysis
      • 7.4.14.6 Strategic initiatives
    • 7.3.15 LG Life Sciences Ltd
      • 7.3.15.1 Company overview
      • 7.3.15.2 Financial performance
      • 7.4.15.3 Product benchmarking
      • 7.4.15.4 Strategic initiatives
      • 7.4.15.5 SWOT analysis
      • 7.4.15.6 Strategic initiatives
    • 7.3.16 Maruha Nichiro, Inc.
      • 7.3.16.1 Company overview
      • 7.3.16.2 Financial performance
      • 7.4.16.3 Product benchmarking
      • 7.4.16.4 Strategic initiatives
      • 7.4.16.5 SWOT analysis
      • 7.4.16.6 Strategic initiatives

Chapter 8 Recommendations

Chapter 9 Research Methodology & Scope

  • 9.1 Research Methodology
    • 9.1.1 Information procurement
      • 9.1.1.1 Purchased database:
      • 9.1.1.2 GVR's internal database
    • 9.1.2 Primary research:
  • 9.2 Research Scope And Assumptions
  • 9.3 List To Data Sources

Chapter 10 Report FAQs

  • 10.1 How Do I Trust Your Report Quality/Data Accuracy?
  • 10.2 My Research Requirement Is Very Specific; Can I Customize This Report?
  • 10.3 I have a pre-defined budget. Can I buy chapters/sections of this report?
  • 10.4 How Do You Arrive At These Market Numbers?
  • 10.5 Who Are Your Clients?
  • 10.6 How Will I Receive This Report?

Chapter 11 Appendix

Chapter 12 Compass - Cloud Based Report Delivery Platform

Chapter 13 Related Reports